| MD | SB791 | Pass | Altering and establishing requirements and prohibitions related to health insurance utilization review; altering requirements related to internal grievance procedures and adverse decision procedures; altering certain reporting requirements on health ... [Detail][Text][Discuss] | 2024-05-16 Approved by the Governor - Chapter 848 |
| MD | HB932 | Pass | Altering and establishing requirements and prohibitions related to health insurance utilization review; altering requirements related to internal grievance procedures and adverse decision procedures; altering certain reporting requirements on health ... [Detail][Text][Discuss] | 2024-05-16 Approved by the Governor - Chapter 847 |
| MD | SB595 | Engross
Sine Die | Requiring administrators, carriers, and pharmacy benefits managers to include certain cost sharing amounts paid by or on behalf of an enrollee or a beneficiary when calculating the enrollee's or beneficiary's contribution to a cost sharing requiremen... [Detail][Text][Discuss] | 2024-04-05 House Refuses Recede |
| MD | HB876 | Engross
Sine Die | Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from excluding coverage for certain specialty drugs that are administered or dispensed by a provider that meets certain criteria; and requiring the rei... [Detail][Text][Discuss] | 2024-03-18 To Senate Finance Committee |
| MD | HB1270 | Intro
Sine Die | Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th... [Detail][Text][Discuss] | 2024-03-16 Withdrawn by Sponsor |
| MD | HB726 | Engross
Sine Die | Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app... [Detail][Text][Discuss] | 2024-03-14 To Senate Finance Committee |
| MD | HB879 | Engross
Sine Die | Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to include certain discounts, financial assistance payments, product vouchers, and other out-of-pocket expenses made by or on behalf of an insured or enr... [Detail][Text][Discuss] | 2024-03-14 To Senate Finance Committee |
| MD | SB497 | Intro
Sine Die | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal... [Detail][Text][Discuss] | 2024-03-04 Withdrawn by Sponsor |
| MD | HB736 | Intro
Sine Die | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal... [Detail][Text][Discuss] | 2024-02-26 Withdrawn by Sponsor |
| MD | HB880 | Intro
Sine Die | Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb... [Detail][Text][Discuss] | 2024-02-09 To House Health and Government Operations Committee |
| MD | HB1368 | Intro
Sine Die | Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or... [Detail][Text][Discuss] | 2024-02-09 To House Health and Government Operations Committee |
| MD | SB1021 | Intro
Sine Die | Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb... [Detail][Text][Discuss] | 2024-02-06 To Senate Finance Committee |
| MD | SB1019 | Intro
Sine Die | Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th... [Detail][Text][Discuss] | 2024-02-06 To Senate Finance Committee |
| MD | SB626 | Intro
Sine Die | Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app... [Detail][Text][Discuss] | 2024-02-02 To Senate Finance Committee |
| MD | SB754 | Intro
Sine Die | Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or... [Detail][Text][Discuss] | 2024-02-02 To Senate Finance Committee |
| MD | SB526 | Intro
Sine Die | Prohibiting certain pharmacy benefits managers from requiring a beneficiary to use a specific pharmacy or entity for a specialty drug if the drug is dispensed by a physician, used in the treatment of a certain condition, and meets other requirements;... [Detail][Text][Discuss] | 2024-01-24 To Senate Finance Committee |